3535 results for «2025年12月15日市值50-100亿服务消费股票推荐»
3535 results
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
01 Apr 2025
Mirvat Alasnag provides her take on the Lancet Commission for atherosclerosis published during the ACC.25 in Chicago.

Author
Jump start the year with PCR Webinars!
08 Jan 2026
Step into 2026 with fresh perspectives! Explore the editorial by Dejan Milasinovic, PCR Webinars Medical Director, and discover the ideas shaping the year ahead.
Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients
26 Sep 2025
Bentley buys key suppliers and engages employees in planned IPO
24 Apr 2023
Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI
05 Aug 2025

Author

Author
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SMT chosen as exclusive distributor of Penumbra’s latest mechanical and computer-aided aspiration technology in India to address blood clots in the heart and body
24 Mar 2023
Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty
18 May 2022
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation
29 Aug 2021
Elad Asher analyses this study which compared the benefits of immediate coronary angiography with those of initial intensive care assessment with delayed angiography after out-of-hospital cardiac arrest. Hot Line session of the ESC Congress 2021.

Author
All-new EuroPCR 2021: what’s on?
SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years
19 Nov 2025
PCR Seminars 2024: education brought to your doorstep!
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.

Author
Celebrating 30 years of transradial artery access!
17 May 2022
Thirty years ago, the interventional cardiology field was transformed with the emergence of a new access site – the radial artery was used for coronary angioplasty and stent implantation for the first time on 14 August 1992.

Author

Author
Bubble trouble: aortic air embolization and de-embolization during coronary angiography
09 Aug 2021
Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...
EXpansion of stents after Intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries: the EXIT-CALC – a prospective, randomized study
20 Sep 2022
Pierre Deharo and Michele Pighi share with us their views on the EXIT-CALC study presented by Thomas Oomens at TCT 2022.

Author

Author
Foldax announces positive one-year data on TRIA Mitral Valve
27 Jun 2025
Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR
06 Aug 2025
Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target
07 Oct 2025
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Author